Based in Billings, Montana, Braxton Norwood is a seasoned healthcare and pharmacology entrepreneur with a wealth of experience in science, medicine, and business.

 

Braxton Norwood is the founder and former CEO of Expesicor, a company focused on preventing, treating, and curing neurological disorders such as Alzheimer's Disease, traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), and epilepsy. During his tenure from 2016 to January 2021, he successfully secured over $4.5 million in private funding and grants, including multiple SBIR grants from the National Institutes of Health. Under his leadership, Expesicor's valuation soared by 250% in 18 months, and the team expanded from two to eleven members in just 2.5 years.

 

To learn more about Braxton Norwood, visit BraxtonNorwood.net.